Skip to main content
Back
NOAH logo

Noah Holdings Limited

Data quality: 100%
NOAH
NYSE Financial Services Asset Management
$11.49
▲ $0.12 (1.06%)
Mkt Cap: 766.94M
Day Range
$11.35 $11.50
52-Week Range
$7.67 $12.84
Volume
143,683
50D / 200D Avg
$11.63 / $11.51
Prev Close
$11.37

Price History

Financial Trends

Peer Comparison

vs Financial Services sector median (854 peers)

Metric Stock Sector Median
P/E 1.6 10.3
P/B 0.1 1.1
ROE % 4.7 11.7
Net Margin % 18.3 16.8
Rev Growth 5Y % -5.8 11.7
D/E 0.0 0.5

Insider Trading Activity

Buy ratio (90d) 0.0%
19 transactions
Date Insider Type Shares Price Value
Mar 18, 2026
Berkowitz Noah
Chief Medical Officer
sell 6,435 $11.10 $71,431
Mar 16, 2026
MacGregor Bannor Michael
CEO
sell 500,000 $0.05 $25,000
Feb 26, 2026
Berkowitz Noah
Chief Medical Officer
grant 112,000
Feb 17, 2026
Stayton Noah Edward
EVP, Chief Information Officer
grant 2,935
Feb 13, 2026
Berkowitz Noah
Chief Medical Officer
sell 5,685 $11.89 $67,595
Jan 23, 2026
Clauser Noah
Chief Financial Officer
sell 317,500
Jan 2, 2026
Glass Noah H.
Director
grant 26,143
Dec 29, 2025
MacGregor Bannor Michael
CEO
sell 1,768,555 $0.10 $232,830
Oct 23, 2025
Popp Noah Nathaniel
EVP, GC and Secretary
grant 3,240
Sep 15, 2025
Popp Noah Nathaniel
EVP, GC and Secretary
grant 2,589 $42.49 $110,007
Aug 21, 2025
Stayton Noah Edward
EVP, Chief Information Officer
grant 11,078
Jun 19, 2025
Elbogen Noah A.
grant 2,747 $45.52 $125,043
Jun 10, 2025
Beren Noah
Director
grant 2,985
May 31, 2025
BRODSKY NOAH
Chief Commercial Officer
other 1,855 $10.50 $19,478
May 9, 2025
Berkowitz Noah
Chief Medical Officer
grant 150,600
Apr 15, 2025
Glass Noah H.
Director
grant 9,933
Mar 31, 2025
BRODSKY NOAH
Chief Commercial Officer
other 1,911
Mar 31, 2025
BRODSKY NOAH
Chief Commercial Officer
grant 25,000
Mar 29, 2025
BRODSKY NOAH
Chief Commercial Officer
other 2,017

Key Takeaways

Revenue declined -5.82% annually over 5 years
Earnings declined -52.90% over the past year
ROE of 4.69% is below average
Net margin of 18.28% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Generating 305.16M in free cash flow

Growth

Revenue Growth (5Y)
-5.82%
Revenue (1Y)-21.06%
Earnings (1Y)-52.90%
FCF Growth (3Y)-26.84%

Quality

Return on Equity
4.69%
ROIC4.72%
Net Margin18.28%
Op. Margin24.37%

Safety

Debt / Equity
0.01
Current Ratio4.53
Interest Coverage0.00

Valuation

P/E Ratio
1.61
P/B Ratio0.08
EV/EBITDA-4.61
Dividend Yield0.84%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -21.06% Revenue Growth (3Y) -8.41%
Earnings Growth (1Y) -52.90% Earnings Growth (3Y) -30.23%
Revenue Growth (5Y) -5.82% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.60B Net Income (TTM) 475.45M
ROE 4.69% ROA 4.04%
Gross Margin 48.12% Operating Margin 24.37%
Net Margin 18.28% Free Cash Flow (TTM) 305.16M
ROIC 4.72% FCF Growth (3Y) -26.84%
Safety
Debt / Equity 0.01 Current Ratio 4.53
Interest Coverage 0.00 Dividend Yield 0.84%
Valuation
P/E Ratio 1.61 P/B Ratio 0.08
P/S Ratio 0.29 PEG Ratio -0.05
EV/EBITDA -4.61 Dividend Yield 0.84%
Market Cap 766.94M Enterprise Value -2.92B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 2.60B 3.29B 3.10B 4.29B 3.31B
Net Income 475.45M 1.01B 976.57M 1.31B -745.23M
EPS (Diluted) 33.75 72.65 71.40 97.25 -60.05
Gross Profit 1.25B 1.84B 1.66B 2.12B 2.61B
Operating Income 633.89M 1.10B 1.09B 1.20B 1.26B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 11.78B 12.69B 11.80B 10.89B 9.40B
Total Liabilities 1.77B 2.26B 2.30B 2.75B 2.12B
Shareholders' Equity 9.95B 10.31B 9.41B 8.04B 7.19B
Total Debt 135.99M 327.06M 177.99M 222.24M 280.86M
Cash & Equivalents 3.82B 5.19B 4.40B 3.40B 5.01B
Current Assets 6.47B 7.12B 6.32B 5.52B 6.70B
Current Liabilities 1.43B 1.89B 1.90B 2.28B 1.88B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026